Ontology highlight
ABSTRACT:
SUBMITTER: Cameron RB
PROVIDER: S-EPMC10504845 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
Cameron Robert B RB Cameron Robert B RB Hines Jacobi B JB Torri Valter V Porcu Luca L Donington Jessica J Bestvina Christine M CM Vokes Everett E Dolezal James M JM Esposito Alessandra A Garassino Marina C MC
Therapeutic advances in medical oncology 20230915
Numerous clinical trials investigating neoadjuvant immune checkpoint inhibitors (ICI) have been performed over the last 5 years. As the number of neoadjuvant trials increases, attention must be paid to identifying informative trial endpoints. Complete pathologic response has been shown to be an appropriate surrogate endpoint for clinical outcomes, such as event-free survival or overall survival, in breast cancer and bladder cancer, but it is less established for non-small-cell lung cancer (NSCLC ...[more]